Original Article Prevalence and Risk Factors of Retinopathy of Prematurity in Iran Mohammad Zarei1, MD; Fatemeh Bazvand1, MD; Nazanin Ebrahimiadib1, MD; Ramak Roohipoor1, MD Reza Karkhaneh1, MD; Afsar Farahani Dastjani1, MD; Marjan Imani Fouladi1, MD; Mohammad Riazi Esfahani1,2, MD; Alireza Khodabande1, MD; Samaneh Davoudi3, MD; Hamed Ghasemi1, MD; Bobeck S Modjtahedi4, MD 1Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran 2Department of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, CA, USA 3Department of Ophthalmology, University of Florida, Gainesville, Florida, USA 4Eye Monitoring Center, Kaiser Permanente Southern California, CA, USA ORCID: Mohammad Zarei: https://orcid.org/0000-0002-8808-2244 Ramak Roohipoor: https://orcid.org/0000-0003-3168-1922 Abstract Purpose: The present study aimed to evaluate the frequency and risk factors of retinopathy of prematurity (ROP) among Iranian infants. Methods: A retrospective cohort study was conducted on infants who had undergone screening for ROP at Farabi Eye Hospital, between March 2016 and March 2017. Data were analyzed based on the presence of extreme prematurity (gestational age ≤ 28 weeks), extremely low-birth-weight (≤ 1000 g), and multiple- gestation (MG) infants. Results: The prevalence of ROP was 27.28% (𝑛 = 543) among all screened infants, 74.4% for extremely preterm (EP) infants, 77.5% for extremely low birth weight (ELBW) babies, and 27.25% for infants from MG pregnancies. On multivariate analysis, gestational age, birth weight, and history of transfusion (𝑃 < 0.0001, 𝑃 < 0.0001, and 𝑃 = 0.04, respectively) were found to be significantly associated with ROP. More advanced stages of ROP (𝑃 < 0.0001) were observed in EP and ELBW infants. Birth weight (𝑃 = 0.088), history of transfusion (𝑃 = 0.066), and intubation (𝑃 = 0.053) were not associated with increased risk of ROP in EP infants, while gestational age (𝑃 = 0.037) and history of transfusion (𝑃 = 0.040) were significant risk factors for ROP in ELBW infants. Gestational age (P < 0.001) and birth weight (𝑃 = 0.001) were significantly associated with ROP in infants from MG pregnancies in multivariate analysis. Conclusion: ROP remains a commonly encountered disease, especially in ELBW and EP infants. The history of transfusion may have a role in stratifying the risk for ROP and guiding future screening guidelines. Keywords: Epidemiology; Frequency; Infants; Pediatric; Retinopathy of Prematurity; Risk Factors J Ophthalmic Vis Res 2019; 14 (3): 291–298 Correspondence to: Ramak Roohipoor, MD. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Tehran 13366, Iran. E-mail: ramakroohipour@yahoo.com Received: 09-03-2018 Accepted: 05-09-2018 Access this article online Website: https://knepublishing.com/index.php/JOVR DOI: 10.18502/jovr.v14i3.4785 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. How to cite this article: Zarei M, Bazvand F, Ebrahimiadib N, Roohipoor R, Karkhaneh R, Dastjani AF, et al. Prevalence and risk factors of retinopathy of prematurity in Iran. J Ophthalmic Vis Res 2019;14:291–298 @ 2019 J  O  V R | PUBLISHED BY KNOWLEDGE E 291 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v14i3.4785&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/JOVR Review of 1,990 Cases of ROP; Zarei et al INTRODUCTION Retinopathy of prematurity (ROP) is the leading cause of visual impairment in premature infants and is characterized by abnormal peripheral retinal vascularization.[1] The incidence of ROP is influ- enced by several factors including gestational age, birth weight, genetics, ethnicity, and level of neona- tal care. Gestational age is defined as the length of time of growth of the fetus in the uterus. Screening programs should be regionally tailored to account for these differences. Advances in prenatal and neonatal care have resulted in increasing rates of ROP in the developing world.[2–4] Gestational age and birth weight are the two most well-established risk factors for ROP, with other factors such as oxygen therapy, history of transfusion, sepsis, and anemia being less signif- icantly associated with ROP.[5] ROP is diagnosed only in a minority of premature infants, with a smaller subset requiring intervention. As a result, better understanding of risk factors of progression to ROP, especially in those cases requiring treat- ment, would allow for more effective screening programs.[5, 6] The purpose of this study is to evaluate the prevalence of ROP and associated risk factors in a tertiary eye center in Tehran. Additional subgroup analysis was done for patients in three high risk categories: extremely low birth weight (≤ 1,000 g, ELBW), extremely preterm (≤ 28 weeks, EP), and multiple gestational (MG) infants. METHODS The current retrospective cohort study was per- formed at Farabi Eye Hospital from March 2016 until March 2017 after obtaining approval from the Institutional Review Board (IRB) of Tehran University of Medical Sciences. The tenets of the Declaration of Helsinki were followed. The medical records of all patients referred to the ROP clinic were assessed. All infants with gestational age ≤ 37 weeks were included in this study. Patients with incomplete medical records were excluded from the analysis. Demographic data (gestational age, birth weight, and gender) and ophthalmic findings (ROP stage, zone, and laterality) were collected and categorized for each patient. Stages of ROP were diagnosed based on the international classification of ROP as follows: Stage 0: immature retinal vasculature without pathologic changes Stage 1: presence of a demarcation line between the vascularized and non-vascularized retina Stage 2: presence of a demarcation line that has height, width, and volume (ridge); small, isolated tufts of neovascular tissue lying on the surface of the retina, commonly known as, “popcorn” may be present. Stage 3: a ridge with extraretinal fibrovascular proliferation that may be mild, moderate, or severe, as judged by the amount of proliferative tissue present. Stage 4: partial retinal detachment (A) Extrafoveal retinal detachment; (B) Retinal detachment involving the fovea Stage 5: total retinal detachment with funnel configuration Threshold is defined as retinal neovasculariza- tion with an extension of either a continuous five clock hour or eight cumulative clock hours in zone I or II with plus disease. Pre-threshold disease is characterized by all zone I and II changes, except zone II stage 1 and zone II stage 2 without plus disease that do not include the criteria of threshold disease, and is divided into two types: Type 1: Zone I, any stage ROP with plus disease, Zone I, stage 3 ROP without plus disease, or Zone III, stage 2 or 3 ROP with plus disease Type 2: Zone I, stage 1 or 2 ROP without plus disease and Zone II, stage 3 ROP without plus disease For the purpose of analysis, the stage of ROP in patients with bilateral disease was categorized based on the eye with the highest stage and lowest zone. Additionally, the history of sepsis, transfusion, acute respiratory distress syndrome (ARDS), oxygen therapy, intubation, intraventric- ular hemorrhage (IVH), and phototherapy were analyzed as risk factors for ROP. Follow-up visits, indications for treatment, types of treatment, and final ROP status at the last examination were also collected for each patient. Data was analyzed using IBM SPSS version 19 (Armonk, NY: IBM Corp). Mean ± standard devi- ation was used to report data. After confirmation 292 J  O  V R Volume 14, Issue 3, July–September 2019 Review of 1,990 Cases of ROP; Zarei et al of the normal distribution of data by Shapiro- Wilk test, the comparison between birth weight and gestational age of patients with and without ROP was performed using student 𝑡-test. Univariate logistic regression was performed to determine the significance of different potential predictive risk factors (gestational age, birth weight, transfusion, sepsis, ARDS, oxygen therapy, intubation, IVH, and phototherapy) in the development of ROP (dependent variable). Subsequently, the resultant significant risk factors were evaluated using multi- variate logistic regression to discern the confound- ing factors. 𝑃-value < 0.05 in the 𝑡-test and logistic regression was considered statistically significant. RESULTS Subjects A total of 1,990 patients met the inclusion criteria. Mean gestational age was 32.29 ± 2.75 weeks (range: 24 ± 37 weeks) and mean birth weight was 1,757.99 ± 563.51 g. The cohort comprised of 51.5% (1024) male infants. Retinopathy of Prematurity The prevalence of ROP was 27.28% (𝑛 = 543). Four hundred and sixty-eight patients (23.52%) had bilateral disease and 75 (3.76%) cases had unilateral disease (23 right eyes and 52 left eyes). Stage of ROP is outlined in Table 1. The mean number of examinations and the mean time to the first examination was 2.4 ± 2.6 (1–36) and 7.6 ± 9.1 weeks, respectively. Cases of ROP diagnosed at initial visit were as follows: Pre-threshold 1 (57 patients, 2.9% of the total number of cases), threshold (77 patients, 3.9%), stage 4a (15 patients, 0.75%), stage 5 (26 patients, 1.3%), regressed ROP with unfavorable outcome (3 patients, 0.15%), and other forms of ROP (pre-threshold 2 and less severe) (365 patients, 18.3%). Thirty-two patients were diagnosed with ROP during follow-up visits. Risk Factors Univariate and multivariate logistic regression anal- yses were performed to examine the relationship between the different risk factors and development of ROP. Gestational age, birth weight, transfusion, ARDS, oxygen therapy, sepsis, intubation, and IVH were significant risk factors on univariate analysis; however, only gestational age, birth weight, and transfusion remained significant on multivariate analysis. [Tables 2 and 3]. Gestational age (𝑃 = 0.010), birth weight (𝑃 < 0.0001), and IVH (𝑃 = 0.028) were significant risk factors for ROP that required treatment. Treatment One hundred and eighty patients underwent treat- ment, which included intravitreal injection of beva- cizumab [IVB, (155 eyes, 86% of patients)], laser (98 eyes, 54%), scleral buckle (5 eyes, 0.05%), vitrectomy (7 eyes, 4%), combination of IVB and scleral buckle (2 eyes, 1%), and combination of IVB and vitrectomy (1 eye, 0.5%). Twenty-nine patients (47 eyes) required retreatment, including 18 eyes with laser (previous treatment included IVB in 16 eyes and laser in 2 eyes), 17 eyes with IVB (previous treatment included IVB in all), 8 eyes with vitrectomy (previous treatment included laser in 4 eyes and IVB in 4 eyes), and 4 eyes with scleral buckle (previous treatment included laser in 2 eyes and IVB in 2 eyes). Seven eyes required a third treatment: vitrectomy in five eyes (all were primarily treated with IVB, followed by laser), and sclera buckle in two eyes (both received IVB followed by vitrectomy). Extremely Preterm Patients Two hundred and twenty-three patients were born EP. Mean gestational age and birth weight were 27.24 ± 0.96 weeks and 1,086.50 ± 268.41 g, respectively. Multi-gestation births (56 patients, 25%), transfusion (142 patients, 63.7%), intubation (34 patients, 15.2%), sepsis (102 patients, 46%), ARDS (176 patients, 79%), oxygen therapy (159 patients, 71%, data of oxygen therapy in 34 patients with ARDS were not documented in the archived files), phototherapy (159 patients, 71%), and IVH (20 patients, 9%) were frequently encountered. One hundred and sixty-six (74.4%) EP patients developed ROP: pre-threshold ROP in 32 patients (14%), threshold ROP in 45 patients (20%), stage 4a in 8 patients (3.6%), stage 5 in 12 patients (5.3%), other stages in 68 patients, and unfavorable structural outcome in 1 patient (0.4%). Stage of ROP was more advanced in EP infants than non-EP infants (chi-square test, 𝑃 < 0.001). J  O  V R Volume 14, Issue 3, July–September 2019 293 Review of 1,990 Cases of ROP; Zarei et al Table 1. The rate and stage of ROP in infants with gestational age equal or less than 37 weeks ROP Right Eye Left Eye Frequency (%) Frequency (%) No ROP 914 (45.9) 904 (45.4) Immature retina (avascular area) 585 (29.4) 566 (28.4) Prethreshold Type 2 and less severe forms of ROP 322 (16.2) 349 (17.5) Pre-threshold ROP Type 1 60 (3) 56 (2.8) Threshold ROP 75 (3.8) 76 (3.8) Stage 4a 11 (0.6) 14 (0.7) Stage 5 21 (1.1) 22 (1.1) Autoregressed ROP with unfavorable outcome 2 (0.1) 3 (0.2) ROP, retinopathy of prematurity Table 2. Data of univariate regression analysis of different risk factors in the development of retinopathy of prematurity With ROP (n = 575) Without ROP (n = 1415) Significance Odds Ratio 95% CI Gestational age 29.98 ± 2.38 33.34 ± 2.50 < 0.001 0.594 0.565–0.620 Birth weight 1,364.95 ± 417.21 1,936 ± 555.64 < 0.001 0.998 0.997–0.998 Gender (female/male) 292/283 674/741 0.211 0.882 0.724–1.074 Multiple gestations (MGs) 183 458 0.908 0.988 0.799–1.280 Oxygen therapy 379 835 < 0.001 3.320 2.347–4.697 Transfusion 229 190 < 0.001 4.269 3.347–5.444 Intra ventricular hemorrhage 31 27 < 0.001 3.035 1.788–5.149 Sepsis 223 422 0.005 1.358 1.097–1.680 ARDS 391 742 < 0.001 3.320 2.347–4.697 Phototherapy 343 826 0.736 0.955 0.729–1.250 Intubation 58 77 < 0.001 2.146 1.493–3.084 ARDS, acute respiratory distress syndrome; CI, confidence interval; ROP, retinopathy of prematurity Fifty-seven (25%) EP patients did not develop ROP (no ROP in 20 patients and immature retina in 37 patients). Birth weight, transfusion, and intu- bation were not significant (although with a trend toward significance) risk factors for ROP in EP infants on multivariate analysis (𝑃 = 0.088, 0.066, and 0.053, respectively). Extremely Low Birth Weight Infants One hundred and sixty patients had ELBW. Trans- fusion (97 patients, 61%), intubation (25 patients, 15.6%), sepsis (66 patients, 41%), ARDS (123 patients, 77%), oxygen therapy (123 patients, 77%), phototherapy (99 patients, 62%), and IVH (14 patients, 8.7%) were commonly observed. One hundred and twenty-four (77.5%) patients were affected by ROP: 24 (15%) patients with Type 1 pre-threshold ROP, 31 (19%) with threshold ROP, 5 (3%) with stage 4a, 10 (6%) with stage 5, and 54 (33.8%) patients with other stages. Thirty-six patients (22.5%) did not develop ROP (no ROP in 12 patients and immature retina in 24 patients). In multivariate analysis, gestational age (𝑃 = 0.037) and transfusion (𝑃 = 0.040) were found to be significantly associated with the development of ROP. 294 J  O  V R Volume 14, Issue 3, July–September 2019 Review of 1,990 Cases of ROP; Zarei et al Table 3. Data of multivariate regression analysis of different risk factors in the development of retinopathy of prematurity Wald Significance Odds Ratio 95% CI Gestational age 64.002 < 0.001 0.724 0.668–0.783 Birth weight 19.313 < 0.001 0.999 0.999–0.999 Gender 0.807 0.369 0.873 0.650–1.174 Multiple gestations .011 0.915 1.017 0.747–1.385 Oxygen therapy 0.463 0.496 1.253 0.655–2.397 Transfusion 3.869 0.049 1.355 1.001–1.833 Intra ventricular hemorrhage 2.094 0.148 1.728 0.824–3.624 Sepsis 1.252 0.263 1.172 0.888–1.547 ARDS 1.686 0.194 1.401 0.842–2.333 Phototherapy 0.125 0.724 0.937 0.652–1.345 Intubation 1.480 0.224 1.349 0.833–2.184 ARDS, acute respiratory distress syndrome; CI, confidence interval Multiple Gestations Six hundred and forty-two babies belonged to MG pregnancies including twins (511 cases, 79.6%), triplets (115 cases, 18%), quadruplets (9 cases, 1.4%), quintuplets (5 cases, 0.8%), and sextuplets (1 case, 0.15%). The mean gestational age was 32.36 ± 2.56 weeks and birth weight was 1,692.94 ± 457.12 g. Transfusion (130 patients, 20%), intubation (39 patients, 6%), sepsis (216 patients, 33.7%), ARDS (369 patients, 57.4%), oxygen therapy (393 patients, 61.2%), phototherapy (399 patients, 62%), and IVH (16 patients, 2.5%) were encountered. One hundred and seventy-five patients (27.2%) developed ROP: Type 1 pre-threshold ROP in 14 patients (2.2%), threshold ROP in 29 patients (4.5%), stage 4a in 7 patients (1%), stage 5 in 5 patients (0.7%), and other stages in 120 patients (18.7%). Four hundred and sixty-seven patients (72.7%) did not develop ROP, of which 181 (28%) had immature retinas. On multivariate analysis, gestational age and birth weight were shown to be significant risk factors associated with ROP (𝑃 < 0.001 and 0.001, respectively). Fifty-eight babies (9%) were treated for ROP. Severity of ROP and the rate of treated cases were similar between MG and single gestation babies. DISCUSSION In this series, the rate of ROP was 27.28% on initial evaluation, with 1.6% developing ROP on subsequent follow-up. The rate of ROP reported in the literature ranges from 11.4 to 44% due to the differences in economic status, ethnicity, genetics, practice setting, screening programs, and level of perinatal care at the respective institutions.[6–14] A previous report from Iran found an 8.5% prevalence of ROP among premature infants.[15] The increased rate observed in the current study may be due to improved perinatal care, which has resulted in longer survival of high-risk infants. There is a considerable debate regarding the risk factors for ROP. In the present cohort, low gestational age and birth weight, history of transfusion, ARDS, oxygen therapy, sepsis, intubation, and IVH were signif- icant risk factors for ROP on univariate analysis; however, on multivariate analysis only gestational age, birth weight, and history of transfusion were found to be statistically significant. Gestational age, birth weight, and IVH were significantly associated with the treatment for ROP among all infants on multivariate analysis (𝑃 = 0.010, < 0.001 and 0.028, respectively). Table 4 provides a summary of the rates of ROP and risk factors across several studies. Multiple studies have identified lower gestational age and birth weight, higher number of days of oxygen therapy, mechanical ventilation, hyper- glycemia, sepsis, transfusion, inadequate weight gain during the first two weeks, and IVH as risk factors for ROP, with low gestational age and birth weight being the most consistently demonstrated risk factors.[6, 8, 11, 12, 16–18] Khalesi et al.[19] observed gestational age, apnea score in the first minute, J  O  V R Volume 14, Issue 3, July–September 2019 295 Review of 1,990 Cases of ROP; Zarei et al Table 4. The rate of development of ROP and significant risk factors in some studies Study Sample size Rate of ROP Risk factors Liu et al[13] 1,846 12.8% Birth weight, gestational age, days of oxygen supplementation, and myocardial injury after birth Chen et al[12] 472 12.7% Gestational age, birth weight, preeclampsia, and maternal oxygen supplement before or at the time of delivery Port et al[6] 1,354 38.8% Birth weight, gestational age, bronchopulmonary dysplasia, multiple gestation (MG), necrotizing enterocolitis, race and ethnicity Mohamed et al[17] 582 29% Univariate analysis: birth weight, gestational age, patent ductus arteriosus, sepsis, intraventricular hemorrhage (IVH), lung disease, days of hyperglycemia, and prescription of postnatal steroids Multivariate analysis: gestational age, days of hyperglycemia, and days of mechanical ventilation Bossi et al[9] 639 11.4% Univariate analysis: extent of O2-exposure, elevated paCO2, elevated paO2, paCO2-fluctuations, transfusions, acidosis, and artificial ventilation Multivariate analysis: acidosis, birth weight, artificial ventilation, multiple birth, and hours of Fio2 greater than 0.4 Mutlu et al[18] 318 37.1% Gestational age ≤ 32 weeks, birth weight ≤ 1250 g, oxygen therapy, and sepsis Kim et al[19] 211 42% Poor weight gain during the first two weeks This study 1,990 28.9% Univariate analysis: gestational age, birth weight, transfusion, ARDS, oxygen therapy, sepsis, intubation, and intraventricular hemorrhage (IVH) Multivariate analysis: gestational age, birth weight, and history of transfusion ARDS, acute respiratory distress syndrome; ROP, retinopathy of prematurity oxygen therapy, and phototherapy as significant risk factors, whereas Dai et al.[5] suggested that maternal iron deficiency may be another significant risk factor in the development of ROP. Increased oxygen demand during sepsis as well as toxic effects of high oxygen production during trans- fusion might result in increased susceptibility to ROP.[20] Similarly, Yau et al.[21] observed that the inci- dence of ROP in patients with a mean gestational age of 26.4 weeks was 60.7%. Lower birth weight, transfusion, and intubation approached statistical significance as risk factors for ROP in the present cohort of EP patients (𝑃 = 0.088, 0.066 and 0.053, respectively). Yau et al[21] retrospectively reviewed EP infants and reported that low gestational age, lighter birth weight, invasive ventilation were sig- nificant risk factors for the development of ROP on univariate analysis. ROP was common in patients with ELBW (77.5%, 𝑛 = 124), which is consistent with the findings reported by Celebi et al (75.5%).[25] A wide spec- trum exists in studies examining the rate of occur- rence of ROP (32.8 ± 82.5%) and the rate of treat- ment for ROP (12.7 ± 48.9%) in ELBW infants.[4, 22–24] In multivariate analysis, we observed that lower gestational age (𝑃 = 0.037) and history of transfu- sion (𝑃 = 0.040) were significant risk factors for the development of ROP in ELBW infants. Celebi et al reported that gestational age, birth weight, history of transfusion, and sepsis were significant factors associated with severe ROP requiring treatment in all infants, while only gestational age was statis- tically significantly associated with ROP requiring treatment in ELBW infants.[25] Among patients born of MG pregnancies, lower gestational age and birth weight were significant risk factors for ROP (𝑃 < 0.001 and 0.001, respec- tively), and no significant difference existed in the severity of ROP and rate of treatment between MG patients and those born of a single gestation. Twin-twin transfusion syndrome has been found to increase the risk for ROP compared to MG alone (𝑃 < 0.01).[26] Yau et al[27] assessed the risk of 296 J  O  V R Volume 14, Issue 3, July–September 2019 Review of 1,990 Cases of ROP; Zarei et al development of Type 1 ROP in MG infants. MG was found to be a significant risk factor using univariate analysis but not in multivariate analysis. Azad et al[28] observed an increased severity of ROP in heavier MG babies and concluded that weight alone cannot be considered a predictive factor for the severity of ROP. Data from the current study support the view that MG is not a risk factor for the development or severity of ROP. The current series presents a contemporary analysis of the rate of ROP and risk factors from a large tertiary center in Iran. The strengths of this study include the large sample size and diverse patient population; however, given the retrospective design, confounding and missing data were innate limitations in the analysis of risk factors for ROP. ROP remains a commonly encountered disease with approximately a quarter of preterm infants and three-quarters ELBW or EP infants being affected. Low birth weight and low gestational age are two essential risk factors for the development of ROP. In both developed and developing countries, low gestational age and low birth weight are the commonly reported risk factors for ROP; however, other factors appear to play a larger role in developing countries. On multivariate analysis, transfusion was a significant risk factor for ROP in ELBW infants and approached statistical significance in EP infants. With improvement in perinatal care in developing countries, the burden of ROP is likely to increase. As a result, a better understanding of the patients at risk for ROP, especially among higher risk sub-groups is critical. Future studies should focus on creating models based on multiple risk factors to stratify the risk of ROP and potentially creating more individualized screening guidelines. Financial Support and Sponsorship Nil. Conflicts of Interest There are no conflicts of interest. REFERENCES 1. Casteels I, Cassiman C, Van Calster J, Allegaert K. Edu- cational paper: Retinopathy of prematurity. Eur J Pediatr 2012;171:887–893. 2. Domanico R, Davis DK, Coleman F, Davis BO. Docu- menting the NICU design dilemma: Comparative patient progress in openward and single family room units. J Perinatol 2011;31:2818. 3. Hellstrm A, Smith LE, Dammann O. Retinopathy of prema- turity. Lancet 2013;382:144557. 4. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al. The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005;116:15– 23. 5. Dai AI, Demiryürek S, Aksoy SN, Perk P, Saygili O, Güngör K. Maternal iron deficiency anemia as a risk factor for the development of retinopathy of prematurity. Pediatr Neurol 2015;53:146–150. 6. Port AD, Paul Chan RV, Ostmo S, Choi D, Chiang MF. Risk factors for retinopathy of prematurity: insights from outlier infants. Graefes Arch Clin Exp Ophthalmol 2014;252:1669–1677. 7. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. The cryotherapy for retinopa- thy of prematurity cooperative group. Ophthalmology 1991;98:1628–1640. 8. Bossi E, Koerner F, Flury B, Zulauf M. Retinopathy of prematurity: A risk factor analysis with univariate and multivariate statistics. Helv Paediatr Acta 1984;39:307– 317. 9. Yin H, Li XX, Li HL, Zhang W. Incidence and risk factor analysis of retinopathy of prematurity. Zhonghua Yan Ke Za Zhi 2005;41:295–299. 10. Chattopadhyay MP, Pradhan A, Singh R, Datta S. Incidence and risk factors for retinopathy of prematurity in neonates. Indian Pediatr 2015;52:157. 11. Chen Y, Xun D, Wang YC, Wang B, Geng SH, Chen H, et al. Incidence and risk factors of retinopathy of prematurity in two neonatal Intensive Care Units in North and South China. Chin Med J 2015;128:914–918. 12. Liu Q, Zin Z, Ke N, Chen L, Chen XK, Fang J, et al. Incidence of retinopathy of prematurity in Southwestern China and analysis of risk factors. Med Sci Monit 2014;20:1442–1451. 13. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity: A multivariate statistical analysis. Ophthalmo- logica 2000;214:131–135. 14. Larsson E, Carle-Petrelius B, Cernerud G, Ots L, Wallin A, Holmstrom G. Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol 2002;86:1122–1126. 15. Saeidi R, Hashemzadeh A, Ahmadi S, Rahmani S. Preva- lence and predisposing factors of retinopathy of prematu- rity in very low-birth-weight infants discharged from NICU. Iran J Pediatr 2009;19:59–63. 16. Mohamed S, Murray JC, Dagle JM, Colaizy T. Hyper- glycemia as a risk factor for the development of retinopa- thy of prematurity. BMC Pediatr 2013;13:78. 17. Mutlu FM, Altinsoy HI, Mumcuoglu T, Kerimoglu H, Kilic S, Kul M, et al. Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey: Frequency, outcomes, and risk factor analysis. J Pediatr Ophthalmol Strabismus 2008;45:291–298. J  O  V R Volume 14, Issue 3, July–September 2019 297 Review of 1,990 Cases of ROP; Zarei et al 18. Kim J, Jin JY, Kim SS. Postnatal weight gain in the first two weeks as a predicting factor of severe retinopa- thy of prematurity requiring treatment. Korean J Pediatr 2015;58:52–59. 19. Khalesi N, Shariat M, Fallahi M, Rostamian G. Evaluation of risk factors for retinopathy in preterm infant: A case-control study in a referral hospital in Iran. Minerva Pediatrica 2015;67:231–237. 20. Weintraub Z, Carmi N, Elouti H, Rumelt S. The association between stage 3 or higher retinopathy of prematurity and other disorders of prematurity. Can J Ophthalmol 2011;46: 419. 21. Yau GS, Lee JW, Tam VT, Liu CC, Wong IY. Risk factors for retinopathy of prematurity in extremely preterm Chinese infants. Medicine (Baltimore) 2014;93:e314. 22. Fortes Filho JB, Eckert GU, Procianoy L, Barros CK, Procianoy RS. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye 2009;23:25–30. 23. Kumar P, Sankar MJ, Deorari A, Azad R, Chandra P, Agarwal R, et al. Risk factors for severe retinopathy of prematurity in preterm low birth weight neonates. Indian J Pediatr 2011;78:812–816. 24. Fortes Filho JB, Borges Fortes BG, Tartarella MB, Pro- cianoy RS. Incidence and main risk factors for severe retinopathy of prematurity in infants weighing less than 1000 grams in Brazil. J Trop Pediatr 2013;59:502–506. 25. Celebi ARC, Petricli IS, Hekimoglu E, Demirel N, Bas AY. The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey. Med Sci Monit 2014;20:1647–1653. 26. Gschlieer A, Stifter E, Neumayer T, Moser E, Papp A, Dorner G, et al. Twin-twin transfusion syndrome as a possible risk factor for the development of retinopa- thy of prematurity. Graefes Arch Clin Exp Ophthalmol 2015;253:151–156. 27. Yau GS, Lee JW, Tam VT, Yip S, Cheng E, Liu CC, et al. Differences in risk factors for retinopathy of prematurity development in paired twins: A Chinese population study. Sci World J 2014;2014:212183. 28. Azad R, Chandra P, Patwardhan SD, Gupta A. Profile of asymmetrical retinopathy of prematurity in twins. Indian J Ophthalmol 2010;58:209–211. 298 J  O  V R Volume 14, Issue 3, July–September 2019